Sort by
Refine Your Search
-
Using cancer and vaccine clinical trials, the project will use RNAseq, epigenetics and flowcytometry, as well as classic immunological techniques. Using cancer and vaccine clinical trials
-
scholarship is available. One scholarship is available. Eligibility requirements: have a first-class Honours or Master's or equivalent degree in a relevant discipline of engineering/science be an Australian
-
health, aged care, information technology or public health. They should have a strong interest in digital health, aged care innovation, and technology-driven healthcare solutions. Candidates must possess
-
mentioning this scholarship, to express their interest and apply through the RMIT application process. Interested candidates who meet the eligibility criteria should contact the primary supervisor, Professor
-
, security, and/or machine learning are preferred. To apply, please submit the following documents to Dr Hai Dong (hai.dong@rmit.edu.au). Expressions of interest should contain the following information: A one
-
. The scholarship is for 3 years; there would be a fee waiver and the standard stipend. One (1). One (1). Refer to eligibility criteria provided at https://www.rmit.edu.au/research/research-degrees/how-to-apply Refer
-
This project will examine the behaviour of nanocarriers at cell/bacteria surfaces and response to biological environments and molecules (such as proteins). Research will utilize a suite of cutting
-
This project is supported by a full scholarship within the context of ARC discovery project DP240101215. Candidates with a background in Chemistry, Chemical Engineering and Materials science are
-
have previous publications or significant research experience. All other applicants will be considered ineligible. Before applying for the Scholarship, contact Anna Hickey-Moody and establish if your
-
Apply via Vietnam based candidates webpage . Apply via Vietnam based candidates webpage . Successful candidates will be expected to have a solid background in finance and sustainable finance, research